Gilead hepatitis C drug faces pricing pressure, but company holds the key
March 24, 2014 at 16:12 PM EDT
No one can dispute that Gilead Sciences Inc. has a breakthrough hepatitis C treatment. The trouble is the public-facing politics around the drug — and that's not a hurdle that the Foster City-based company is jumping over easily...
